English Medical Medical (general) clinical trials

These Asia-Pacific countries are ideal locations for clinical trials due to access to many treatment naive patients across a variety of disease areas, local medical expertise and infrastructure, standard of care that is comparable to developed countries and, regulatory ease. Sponsors ***will have increased access*** to an additional 200M+ patient population while in close proximity to the XXX organization. This scenario coupled with a high number of English speaking and well-qualified physicians provides the same advantages as India offers both in terms of quality and cost-effectiveness for conducting clinical trials.

Does this mean "will have an increased access to"? or "will have increased the access to"?